Current Approaches in Familial Colorectal Cancer: A Clinical Perspective

By Lynch Patrick M.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 4, 2006-04 ,pp. : 421-430

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Drugs in preclinical and early-stage clinical development for pancreatic cancer

By Asuthkar Swapna   Rao Jasti S   Gondi Christopher S  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 143-152

Informa Healthcare

Access to resources Recommend Favorite

Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases

By  

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2272-2314

Bentham Science Publishers

Access to resources Recommend Favorite

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

By Serdjebi Cindy   Seitz Jean-François   Ciccolini Joseph   Duluc Muriel   Norguet Emmanuelle   Fina Frédéric   Lacarelle Bruno   Ouafik L'Houcine   Dahan Laetitia  

Pharmacogenomics, Vol. 14, Iss. 9, 2013-07 ,pp. : 1047-1051

Future Medicine

Access to resources Recommend Favorite

Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine

By Woo Hye In   Kim Ka-Kyung   Choi Hangseok   Kim Seonwoo   Jang Kee-Taek   Yi Jun Ho   Park Young Suk   Park Joon Oh   Lee Soo-Youn  

Pharmacogenomics, Vol. 13, Iss. 9, 2012-07 ,pp. : 1023-1035

Future Medicine

Access to resources Recommend Favorite